Literature DB >> 33333772

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.

Stefania Petrosino1,2, Aniello Schiano Moriello1,2.   

Abstract

Neuroinflammation is a physiological response aimed at maintaining the homodynamic balance and providing the body with the fundamental resource of adaptation to endogenous and exogenous stimuli. Although the response is initiated with protective purposes, the effect may be detrimental when not regulated. The physiological control of neuroinflammation is mainly achieved via regulatory mechanisms performed by particular cells of the immune system intimately associated with or within the nervous system and named "non-neuronal cells." In particular, mast cells (within the central nervous system and in the periphery) and microglia (at spinal and supraspinal level) are involved in this control, through a close functional relationship between them and neurons (either centrally, spinal, or peripherally located). Accordingly, neuroinflammation becomes a worsening factor in many disorders whenever the non-neuronal cell supervision is inadequate. It has been shown that the regulation of non-neuronal cells-and therefore the control of neuroinflammation-depends on the local "on demand" synthesis of the endogenous lipid amide Palmitoylethanolamide and related endocannabinoids. When the balance between synthesis and degradation of this bioactive lipid mediator is disrupted in favor of reduced synthesis and/or increased degradation, the behavior of non-neuronal cells may not be appropriately regulated and neuroinflammation exceeds the physiological boundaries. In these conditions, it has been demonstrated that the increase of endogenous Palmitoylethanolamide-either by decreasing its degradation or exogenous administration-is able to keep neuroinflammation within its physiological limits. In this review the large number of studies on the benefits derived from oral administration of micronized and highly bioavailable forms of Palmitoylethanolamide is discussed, with special reference to neuroinflammatory disorders.

Entities:  

Keywords:  dietary food; endocannabinoid system; mast cells; neuroinflammation; nutrient; palmitoylethanolamide

Year:  2020        PMID: 33333772     DOI: 10.3390/ijms21249526

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  10 in total

1.  Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO.

Authors:  Matthias Zaiss; Jens Uhlig; Mark-Oliver Zahn; Thomas Decker; Helmar C Lehmann; Johanna Harde; Cathrin Hogrefe; Corinne Vannier; Norbert Marschner
Journal:  Oncol Res Treat       Date:  2021-09-08       Impact factor: 2.825

Review 2.  Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials.

Authors:  Lorenzo Lippi; Alessandro de Sire; Arianna Folli; Francesco D'Abrosca; Elisa Grana; Alessio Baricich; Stefano Carda; Marco Invernizzi
Journal:  Toxins (Basel)       Date:  2022-04-27       Impact factor: 5.075

3.  Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications.

Authors:  Loredana Raciti; Francesca Antonia Arcadi; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

Review 4.  Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans.

Authors:  Eugenia Landolfo; Debora Cutuli; Laura Petrosini; Carlo Caltagirone
Journal:  Biomolecules       Date:  2022-05-05

Review 5.  Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes.

Authors:  Marta Valenza; Roberta Facchinetti; Giorgia Menegoni; Luca Steardo; Caterina Scuderi
Journal:  Biomolecules       Date:  2021-04-19

Review 6.  Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.

Authors:  Aniello Schiano Moriello; Vincenzo Di Marzo; Stefania Petrosino
Journal:  Animals (Basel)       Date:  2022-01-31       Impact factor: 2.752

7.  Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention.

Authors:  Laura Micheli; Elena Lucarini; Alessandra Toti; Valentina Ferrara; Clara Ciampi; Carmen Parisio; Gianluca Bartolucci; Lorenzo Di Cesare Mannelli; Carla Ghelardini
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

Review 8.  Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art.

Authors:  Giorgia Della Rocca; Giovanni Re
Journal:  Biomolecules       Date:  2022-08-26

Review 9.  Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.

Authors:  Kunio Yui; George Imataka; Shigemi Yoshihara
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

Review 10.  Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?

Authors:  Giorgia Della Rocca; Davide Gamba
Journal:  Animals (Basel)       Date:  2021-03-29       Impact factor: 2.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.